Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://tiffanywngd367571.sharebyblog.com/38861679/trelaglutide-exploring-a-new-treatment-for-chronic-diseases